Injection site swelling: FDA reporting patterns
74,777 FDA FAERS reports mention Injection site swelling. 11,531 reports have a serious outcome flag.
Medicines named as suspect
- Etanercept: 23,251 reports
- Dupilumab: 11,889 reports
- Adalimumab: 8,236 reports
- Evolocumab: 2,010 reports
- Glatiramer: 1,993 reports
- Ixekizumab: 1,648 reports
- Tirzepatide: 1,608 reports
- Onabotulinumtoxina: 1,009 reports
- Hydroxyprogesterone: 942 reports
- Human Immunoglobulin G: 920 reports
- Certolizumab Pegol: 912 reports
- Exenatide: 907 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.